{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:27:31Z","timestamp":1783643251803,"version":"3.55.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.medcli.2024.07.020","type":"journal-article","created":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T10:53:52Z","timestamp":1728471232000},"page":"595-599","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Hiperparatiroidismo en pacientes con baja densidad mineral \u00f3sea tratados con \u00e1cido zoledr\u00f3nico o denosumab"],"prefix":"10.1016","volume":"163","author":[{"given":"Carmen","family":"Riesco-B\u00e1rcena","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Ivorra-Cort\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Grau-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Gonz\u00e1lez-Puig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Leal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anderson","family":"Huaylla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Rom\u00e1n-Ivorra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2024.07.020_bib0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.berh.2022.101780","article-title":"Osteoporosis and Fragility Fractures: currently available pharmacological options and future directions","volume":"36","author":"Dimai","year":"2022","journal-title":"Best Pract Res Clin Rheumatol."},{"key":"10.1016\/j.medcli.2024.07.020_bib0085","author":"Greear","year":"2023","journal-title":"Zoledronate. StatPearls [Internet]"},{"key":"10.1016\/j.medcli.2024.07.020_bib0090","author":"Levis","year":"2012","journal-title":"Summary of AHRQ's Comparative Effectiveness Review of Treatment to Prevent Fractures in Men and Women with Low Bone Density or Osteoporosis: Update of the 2007 Report PRIME CME\/CNE Reviewers."},{"key":"10.1016\/j.medcli.2024.07.020_bib0095","first-page":"101","article-title":"Hyperparathyroidism Following Denosumab and Zoledronate Therapy in a Secondary Care Setting","volume":"29","author":"Kotecha","year":"2023","journal-title":"J Clin Rheumatol."},{"key":"10.1016\/j.medcli.2024.07.020_bib0100","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/cen.12188","article-title":"Parathyroid hormone changes following denosumab treatment in postmenopausal osteoporosis","volume":"79","author":"Makras","year":"2013","journal-title":"Clin Endocrinol (Oxf)."},{"key":"10.1016\/j.medcli.2024.07.020_bib0105","doi-asserted-by":"crossref","first-page":"666","DOI":"10.20945\/2359-3997000000556","article-title":"Normocalcemic primary hyperparathyroidism","volume":"66","author":"Cusano","year":"2022","journal-title":"Arch Endocrinol Metab."},{"key":"10.1016\/j.medcli.2024.07.020_bib0110","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1056\/NEJMoa044459","article-title":"Denosumab in postmenopausal women with low bone mineral density","volume":"354","author":"McClung","year":"2006","journal-title":"N Engl J Med."},{"key":"10.1016\/j.medcli.2024.07.020_bib0115","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1681\/ASN.2010020186","article-title":"The regulation of parathyroid hormone secretion and synthesis","volume":"22","author":"Kumar","year":"2011","journal-title":"J Am Soc Nephrol."},{"key":"10.1016\/j.medcli.2024.07.020_bib0120","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/S0272-6386(97)90330-9","article-title":"The Importance of Dietary Calcium and Phosphorous in the Secondary Hyperparathyroidism of Patients With Early Renal Failure","volume":"29","author":"Martinez","year":"1997","journal-title":"Am J Kidney Dis."},{"key":"10.1016\/j.medcli.2024.07.020_bib0125","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1111\/bcp.13332","article-title":"Effect of a single intravenous zoledronic acid administration on biomarkers of acute kidney injury (AKI) in patients with osteoporosis: a pilot study","volume":"83","author":"Cipriani","year":"2017","journal-title":"Br J Clin Pharmacol."},{"key":"10.1016\/j.medcli.2024.07.020_bib0130","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00198-023-06926-0","article-title":"Prevalence of denosumab-induced hypocalcemia: a retrospective observational study of patients routinely monitored with ionized calcium post-injection","volume":"35","author":"Sp\u00e5ngeus","year":"2024","journal-title":"Osteoporosis International."},{"key":"10.1016\/j.medcli.2024.07.020_bib0135","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s00223-014-9840-0","article-title":"Vitamin D status and parathyroid hormone concentrations influence the skeletal response to zoledronate and denosumab","volume":"94","author":"Mosali","year":"2014","journal-title":"Calcif Tissue Int [Internet]."},{"key":"10.1016\/j.medcli.2024.07.020_bib0140","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ando.2015.03.005","article-title":"How to manage an isolated elevated PTH?","volume":"76","author":"Souberbielle","year":"2015","journal-title":"Ann Endocrinol (Paris)."},{"key":"10.1016\/j.medcli.2024.07.020_bib0145","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1359\/JBMR.040305","article-title":"A single-dose placebo-controlled study of AMG 162, a fully human monoclonal antibody to RANKL, in postmenopausal women","volume":"19","author":"Bekker","year":"2004","journal-title":"J Bone Miner Res."},{"key":"10.1016\/j.medcli.2024.07.020_bib0150","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1210\/jc.2008-2241","article-title":"The antiresorptive effects of a single dose of zoledronate persist for two years: A randomized, placebo-controlled trial in osteopenic postmenopausal women","volume":"94","author":"Grey","year":"2009","journal-title":"J Clin Endocrinol Metab."}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775324005232?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775324005232?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T13:55:48Z","timestamp":1733838948000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775324005232"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":15,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S0025775324005232"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2024.07.020","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hiperparatiroidismo en pacientes con baja densidad mineral \u00f3sea tratados con \u00e1cido zoledr\u00f3nico o denosumab","name":"articletitle","label":"Article Title"},{"value":"Medicina Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medcli.2024.07.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}